Literature DB >> 9711998

Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

G De Mattia1, M C Bravi, O Laurenti, M Cassone-Faldetta, A Armiento, C Ferri, F Balsano.   

Abstract

To evaluate the relationship between oxidative stress and glucose metabolism, insulin sensitivity and intraerythrocytic reduced glutathione (GSH)/oxidized glutathione (GSSG) ratio were measured in 10 non-insulin-dependent diabetes mellitus (NIDDM) patients and 10 healthy subjects before and after the intravenous administration of GSH. In particular, after baseline insulin sensitivity was assessed by a 2-hour euglycemic hyperinsulinemic clamp, either glutathione (1.35 g x m2 x min(-1)) or placebo (saline) were infused over a period of 1 hour. The same protocol was repeated at a 1-week interval, in cross-over, according to a randomized, single-blind design. In healthy subjects, baseline intraerythrocytic GSH/GSSG ratio (P < .0005) and total glucose uptake (P < .005) were significantly higher than in NIDDM patients. In the same subjects, GSH infusion significantly increased total glucose uptake (from 37.1 +/- 6.7 micromol kg(-1) x min(-1) to 39.5 +/- 7.7 micromol x kg(-1) x min(-1), P < .05), whereas saline infusion was completely ineffective. In addition, the mean intraerythrocytic GSH/GSSG ratio significantly increased after GSH infusion (from 21.0 +/- 0.9 to 24.7 +/- 1.3, P < .05). Similar findings were found in diabetic patients, in whom GSH infusion significantly increased both total glucose uptake (from 25.3 +/- 9.0 micromol x kg(-1) x min(-1) to 31.4 +/- 10.0 micromol x kg(-1) x min(-1), P < .001) and intraerythrocytic GSH/GSSG ratio (from 14.8 +/- 4.1 to 21.7 +/- 6.7, P < .01). Pooling diabetic patients and controls, significant correlations were found between intraerythrocytic GSH/GSSG ratio and total glucose uptake (r = .425, P < .05), as well as between increments of the same variables after GSH infusion (r = .518, P < .05). In conclusion, our data support the hypothesis that abnormal intracellular GSH redox status plays an important role in reducing insulin sensitivity in NIDDM patients. Accordingly, intravenous GSH infusion significantly increased both intraerythrocytic GSH/GSSG ratio and total glucose uptake in the same patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711998     DOI: 10.1016/s0026-0495(98)90357-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

Review 1.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

Review 2.  Risk of postprandial insulin resistance: the liver/vagus rapport.

Authors:  Maria Paula Macedo; Inês S Lima; Joana M Gaspar; Ricardo A Afonso; Rita S Patarrão; Young-Bum Kim; Rogério T Ribeiro
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

3.  Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes.

Authors:  Sushil K Jain; David Micinski
Journal:  Biochem Biophys Res Commun       Date:  2013-06-11       Impact factor: 3.575

4.  The effect of glutathione treatment on the biochemical and immunohistochemical profile in streptozotocin-induced diabetic rats.

Authors:  Fatmagül Yur; Semiha Dede; Turan Karaca; Sevim Ciftçi Yegin; Yeter Değer; Hülya Ozdemir
Journal:  J Membr Biol       Date:  2013-05-17       Impact factor: 1.843

5.  Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men.

Authors:  C Xiao; A Giacca; G F Lewis
Journal:  Diabetologia       Date:  2007-11-17       Impact factor: 10.122

6.  Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats.

Authors:  Maria P Guarino; M Paula Macedo
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

7.  Exposure to Static Magnetic and Electric Fields Treats Type 2 Diabetes.

Authors:  Calvin S Carter; Sunny C Huang; Charles C Searby; Benjamin Cassaidy; Michael J Miller; Wojciech J Grzesik; Ted B Piorczynski; Thomas K Pak; Susan A Walsh; Michael Acevedo; Qihong Zhang; Kranti A Mapuskar; Ginger L Milne; Antentor O Hinton; Deng-Fu Guo; Robert Weiss; Kyle Bradberry; Eric B Taylor; Adam J Rauckhorst; David W Dick; Vamsidhar Akurathi; Kelly C Falls-Hubert; Brett A Wagner; Walter A Carter; Kai Wang; Andrew W Norris; Kamal Rahmouni; Garry R Buettner; Jason M Hansen; Douglas R Spitz; E Dale Abel; Val C Sheffield
Journal:  Cell Metab       Date:  2020-10-06       Impact factor: 27.287

8.  FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.

Authors:  Sandra Pereira; Edward Park; Yusaku Mori; C Andrew Haber; Ping Han; Toyoyoshi Uchida; Laura Stavar; Andrei I Oprescu; Khajag Koulajian; Alexander Ivovic; Zhiwen Yu; Deling Li; Thomas A Bowman; Jay Dewald; Jamel El-Benna; David N Brindley; Roger Gutierrez-Juarez; Tony K T Lam; Sonia M Najjar; Robert A McKay; Sanjay Bhanot; I George Fantus; Adria Giacca
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-13       Impact factor: 4.310

Review 9.  Glutathione dysregulation and the etiology and progression of human diseases.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Sylvia Notenboom; Shujie Shi; Kim Tieu; Christine L Hammond
Journal:  Biol Chem       Date:  2009-03       Impact factor: 3.915

10.  Personalized metabolic assessment of erythrocytes using microfluidic delivery to an array of luminescent wells.

Authors:  Nicole V Tolan; Luiza I Genes; Wasanthi Subasinghe; Madushi Raththagala; Dana M Spence
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.